Who is sponsoring NCT04615078?

NCT04615078 is sponsored by Air Liquide Santé International.

What drugs are being tested in NCT04615078?

Interventions in NCT04615078: ETAPES Program.

What condition does NCT04615078 study?

NCT04615078 studies Chronic Respiratory Failure With Hypercapnia, Chronic Obstructive Pulmonary Disease (COPD), Obesity Hypoventilation Syndrome (OHS).

Is NCT04615078 still recruiting?

NCT04615078 is currently completed. Last updated 26 June 2023.

Last reviewed 2023-06-26 · How we verify

NCT04615078: e-VENT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation

Completed NA Last updated 26 June 2023

What this trial tests

NA trial testing ETAPES Program in Chronic Respiratory Failure With Hypercapnia in 56 participants. Completed in 25 July 2022.

Timeline

18 January 2021

Primary endpoint
25 July 2022

25 July 2022

Quick facts

Lead sponsor	Air Liquide Santé International
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	56
Start date	18 January 2021
Primary completion	25 July 2022
Estimated completion	25 July 2022
Sites	11 locations across France

Drugs / interventions tested

ETAPES Program

Conditions studied

Chronic Respiratory Failure With Hypercapnia — all drugs for Chronic Respiratory Failure With Hypercapnia →
Chronic Obstructive Pulmonary Disease (COPD) — all drugs for Chronic Obstructive Pulmonary Disease (COPD) →
Obesity Hypoventilation Syndrome (OHS) — all drugs for Obesity Hypoventilation Syndrome (OHS) →

Sponsor

Air Liquide Santé International — full company profile →

Who can join

18 and older, any sex, with Chronic Respiratory Failure With Hypercapnia or Chronic Obstructive Pulmonary Disease (COPD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ETAPES Program, a French national Experimentation in Telemedicine for the Improvement of Healthcare Pathways, was launched in 2018 for 4 years. Its objectives were to provide a temporary public reimbursement for medical telemonitoring in order to determine the benefits for the patient and the impact on medical organization and healthcare costs. In particular, this program applies to patients suffering from hypercapnic chronic respiratory failure and requiring home non invasive ventilation (NIV). For these patients, the ETAPES program combines NIV telemonitoring and therapeutic education. e-VENT study aims at evaluating the ETAPES program, implemented using the Chronic Care Connect™ telemonitoring solution, versus Standard of Care, on the effectiveness of home NIV, measured by average PtCO2, reflecting the level of nocturnal alveolar hypoventilation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Real-world telemonitoring and remote support for home non-invasive ventilation to improve therapy effectiveness: the exploratory, multicentre randomised eVENT study.
Prigent A, Texereau JB, Schmitz C, Ropars C, et al · · 2025 · cited 3× · PMID 40169180 · DOI 10.1136/thorax-2024-222033

Verify or expand the search:

Other Air Liquide Santé International trials

Trials by the same sponsor.

NCT05793645 — Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program · NA · unknown
NCT05246449 — Evaluate the Benefit of an Individualised Treatment Plan (VitalCare) VS SOC in OSA Patients Treated With CPAP/APAP · NA · completed
NCT04635280 — Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Close · NA · completed
NCT04233229 — Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 · NA · completed
NCT03436212 — Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04615078 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Air Liquide Santé International
Last refreshed: 26 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04615078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing